Abstract
Cytosolic PEPCK deficiency (PCKDC) is a rare autosomal recessive inborn error of metabolism, which can present with hypoglycemia, lactic acidosis, and liver failure. It is caused by biallelic pathogenic variants in the PCK1 gene. Only four PCK1 variants have been previously reported in seven patients with PCKDC, and their clinical course of this condition has not been well characterized. Here, we report a Hispanic male with novel biallelic PCK1 variants, p.(Gly430Asp) and p.(His496Gln), who had a unique clinical presentation. He presented with a new onset of growth failure, elevated blood lactate, transaminitis, and abnormal urine metabolites profile, but he has not had documented hypoglycemia. Growth restriction happened due to insufficient caloric intake, and it was improved with nutritional intervention. PCKDC is a manageable disorder and therefore appropriate nutritional and clinical suspicion from typical lab abnormalities which lead to molecular confirmation tests are essential to prevent poor clinical outcomes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yang J, Kalhan SC, Hanson RW. What is the metabolic role of phosphoenolpyruvate carboxykinase? J Biol Chem. 2009;284:27025–9.
Soty M, Gautier-Stein A, Rajas F, Mithieux G. Gut-brain glucose signaling in energy homeostasis. Cell Metab. 2017;25:1231–42.
Chourpiliadis C, Mohiuddin SS. Biochemistry, gluconeogenesis. Treasure Island, FL: StatPearls; 2020.
Beale EG, Harvey BJ, Forest C. PCK1 and PCK2 as candidate diabetes and obesity genes. Cell Biochem Biophys. 2007;48:89–95.
Mendez-Lucas A, Duarte JA, Sunny NE, Satapati S, He T, Fu X, et al. PEPCK-M expression in mouse liver potentiates, not replaces, PEPCK-C mediated gluconeogenesis. J Hepatol. 2013;59:105–13.
Chaturvedi S, Singh AK, Keshari AK, Maity S, Sarkar S, Saha S. Human metabolic enzymes deficiency: a genetic mutation based approach. Science. 2016;2016:9828672.
Santra S, Cameron JM, Shyr C, Zhang L, Drogemoller B, Ross CJ, et al. Cytosolic phosphoenolpyruvate carboxykinase deficiency presenting with acute liver failure following gastroenteritis. Mol Genet Metab. 2016;118:21–7.
Vieira P, Cameron J, Rahikkala E, Keski-Filppula R, Zhang LH, Santra S, et al. Novel homozygous PCK1 mutation causing cytosolic phosphoenolpyruvate carboxykinase deficiency presenting as childhood hypoglycemia, an abnormal pattern of urine metabolites and liver dysfunction. Mol Genet Metab. 2017;120:337–41.
Al-Murshedi F, Meftah D, Scott P. Underdiagnoses resulting from variant misinterpretation: time for systematic reanalysis of whole exome data? Eur J Med Genet. 2019;62:39–43.
DaRe JT, Vasta V, Penn J, Tran NT, Hahn SH. Targeted exome sequencing for mitochondrial disorders reveals high genetic heterogeneity. BMC Med Genet. 2013;14:118.
Saraste M, Sibbald PR, Wittinghofer A. The P-loop-a common motif in ATP- and GTP-binding proteins. Trends Biochem Sci. 1990;15:430–4.
Delbaere LT, Sudom AM, Prasad L, Leduc Y, Goldie H. Structure/function studies of phosphoryl transfer by phosphoenolpyruvate carboxykinase. Biochim Biophys Acta. 2004;1697:271–8.
Hommes FA, Bendien K, Elema JD, Bremer HJ, Lombeck I. Two cases of phosphoenolpyruvate carboxykinase deficiency. Acta Paediatr Scand. 1976;65:233–40.
Vidnes J, Sovik O. Gluconeogenesis in infancy and childhood. III. Deficiency of the extramitochondrial form of hepatic phosphoenolpyruvate carboxykinase in a case of persistent neonatal hypoglycaemia. Acta Paediatr Scand. 1976;65:307–12.
Adams DR, Yuan H, Holyoak T, Arajs KH, Hakimi P, Markello TC, et al. Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity. Mol Genet Metab. 2014;113:161–70.
Semakova J, Hyrossova P, Mendez-Lucas A, Cutz E, Bermudez J, Burgess S, et al. PEPCK-C reexpression in the liver counters neonatal hypoglycemia in Pck1 (del/del) mice, unmasking role in non-gluconeogenic tissues. J Physiol Biochem. 2017;73:89–98.
Gandhi K. Approach to hypoglycemia in infants and children. Transl Pediatr. 2017;6:408–20.
Blau N, Duran M, Blaskovics ME, Gibson KM, editors. Physician’s guide to the laboratory diagnosis of metabolic diseases. 2nd ed. Berlin, Heidelberg, New York: Springer Science & Business Media Press; 2012.
Rinaldo P Organic Acids. In: Blau N, Duran M, Gibson KM, editors. Laboratory guide to the methods in biochemical genetics. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg; 2008. p. 137–69.
Acknowledgements
We would like to thank the patient and his family for their contribution to this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
HC is a paid employee of Sema4. The other authors have no conflicts of interest to declare.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Oishi, K., Siegel, C., Cork, E.E. et al. Novel missense variants in PCK1 gene cause cytosolic PEPCK deficiency with growth failure from inadequate caloric intake. J Hum Genet 66, 321–325 (2021). https://doi.org/10.1038/s10038-020-00823-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-020-00823-8